The nation of Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) spanning five years over Washington's request for sensitive information.
This move was revealed after a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later stated that the United States was seeking biological samples for scientific study and commercial purposes but was unwilling to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged continued negotiations to find a deal acceptable to both sides so the nation's critical HIV programme can be sustained.
Wider Implications
This development follows a similar case in Kenya, where a court halted a related deal with the US following legal challenges were filed about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.
As per statements, 16 nations in Africa have to date agreed to similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be available to our population if a new disease outbreak arise."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures previously set up through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks need to persist since much of the country's HIV programmes relied on international support.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal highlights the ongoing debate between accepting vital foreign assistance and protecting national sovereignty in an ever more interconnected world.